DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 118 filers reported holding DYNE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $24,975,383 | 32.61% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $55,702,159 | 27.32% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $111,211,301 | 13.84% |
| VR Adviser, LLC | 2,173,913 | $24,456,521 | 3.91% |
| TCG Crossover Management, LLC | 1,650,150 | $18,564,188 | 3.04% |
| Logos Global Management LP | 1,780,000 | $20,025,000 | 2.72% |
| Altium Capital Management LP | 155,000 | $1,743,750 | 1.32% |
| Deep Track Capital, LP | 2,499,912 | $28,124,010 | 1.30% |
| Octagon Capital Advisors LP | 692,945 | $7,795,631 | 1.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,751 | $3,383,449 | 1.03% |
| Nantahala Capital Management | 593,164 | $6,673,095 | 0.64% |
| ACUTA CAPITAL PARTNERS, LLC | 73,000 | $821,250 | 0.56% |
| BRAIDWELL LP | 1,377,872 | $15,501,060 | 0.51% |
| Vivo Capital, LLC | 577,642 | $6,498,473 | 0.45% |
| Sofinnova Investments, Inc. | 441,048 | $4,961,790 | 0.32% |
| Artal Group S.A. | 815,085 | $9,170 | 0.28% |
| EcoR1 Capital, LLC | 798,701 | $8,985,386 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 119,918 | $1,349,078 | 0.21% |
| WASATCH ADVISORS LP | 2,259,535 | $25,419,769 | 0.15% |
| ARMISTICE CAPITAL, LLC | 912,000 | $10,260,000 | 0.15% |
External links
This page lists DYNE THERAPEUTICS INC's shareholders in Q2 2023. To view DYNE THERAPEUTICS INC's shareholder history, click here.